What Do Analysts Think About UniQure (QURE)?

UniQure (NASDAQ:QURE) is one of the best small cap stocks to buy with huge upside potential. Stifel slashed the price target on UniQure (NASDAQ:QURE) to $40 from $50 on December 11, keeping a Buy rating on the stock and stating that it “refreshed diligence” on several companies under its coverage in the biotechnology sector. The firm added that it made several estimate, model, and price target changes for a 2026 look ahead note for the sector.

UniQure (NASDAQ:QURE) also received a rating update from Mizuho analyst Uy Ear on December 8, who lowered the price target to $33 from $60 while keeping an Outperform rating on the stock. The firm cited the lowering of its view of the company’s probability of success and expected launch year for AMT-130 by one year.

This followed UniQure’s (NASDAQ:QURE) announcement on December 4 that it received the final meeting minutes from the FDA regarding the pre-Biologics License Application (BLA) meeting that was held on October 29 to discuss the application for AMT-130. AMT-130 is an investigational gene therapy for Huntington’s disease (HD).

Management reported that the FDA conveyed in the final meeting minutes that the submitted data from the Phase I/II studies of AMT-130 was currently unlikely to offer the primary evidence that could support a BLA submission. UniQure (NASDAQ:QURE) stated that it is evaluating the feedback carefully, and has plans to urgently request a follow-up meeting with the FDA for fiscal Q1 2026.

UniQure (NASDAQ:QURE) discovers, develops, and commercializes innovative gene therapies, with its discoveries focused on treating Huntington’s disease, glybera, hemophilia, and cardiovascular problems.

While we acknowledge the potential of QURE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.